(c) 2024 PillSync.com

montelukast sodium tablet chewable

1 INDICATIONS AND USAGE Montelukast sodium chewable tablets are a leukotriene receptor antagonist indicated for: • Prophylaxis and chronic treatment of asthma in patients 2 years of age and older ( 1.1 ). • Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older ( 1.2 ). • Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2 years of age and older, and perennial allergic rhinitis (PAR) in patients 2 years of age and older. Reserve use for patients who have an inadequate response or intolerance to alternative therapies ( 1.3 ). 1.1 Asthma Montelukast sodium chewable tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 2 years of age and older. 1.2 Exercise-Induced Bronchoconstriction (EIB) Montelukast sodium chewable tablets are indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older. 1.3 allergic rhinitis sodium chewable tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 of age and older. Because the benefits of montelukast sodium chewable tablets may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis , use for patients who have an inadequate response or intolerance to alternative therapies. Montelukast sodium chewable tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 years of age and older. Because the benefits of montelukast sodium chewable tablets may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis [see warnings and precautions ( 5.1 )] , reserve use for patients who have an inadequate response or intolerance to alternative therapies.

camber pharmaceuticals, inc.


5 years ago OVAL PINK I 112 montelukast sodium tablet chewable

OVAL PINK I 112

5 years ago OVAL PINK I 112 montelukast sodium tablet chewable

I 112 OVAL PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

MONTELUKAST SODIUM Chewable Tablets 4 mg are light pink to pink colored, speckled, oval, biconvex shaped, chewable tablets debossed with 'I' on one side and '112' on the other side. They are supplied as follows: Bottles of 30 tablets NDC 31722-727-30 Bottles of 90 tablets NDC 31722-727-90 Bottles of 100 tablets NDC 31722-727-01 Bottles of 1000 tablets NDC 31722-727-10 Blister card of 10 Unit-dose tablets NDC 31722-727-31 Blister pack of 100 (10 x 10) Unit-dose tablets NDC 31722-727-32

MONTELUKAST SODIUM Chewable Tablets 5 mg are light pink to pink colored, speckled, round, biconvex shaped, chewable tablets debossed with 'I' on one side and '113' on the other side. Bottles of 30 tablets NDC 31722-728-30 Bottles of 90 tablets NDC 31722-728-90 Bottles of 100 tablets NDC 31722-728-01 Bottles of 1000 tablets NDC 31722-728-10 Blister card of 10 Unit-dose tablets NDC 31722-728-31 Blister pack of 100 (10 x 10) Unit-dose tablets NDC 31722-728-32 . Storage Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture and light. Store in original container. When product container is subdivided, repackage into a well-closed, light-resistance container.


More pills like OVAL I 112

Related Pills

montelukast sodium 5 mg

camber pharmaceuticals, inc.

acyclovir tablet

carlsbad technology, inc.

acyclovir tablet

carlsbad technology, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site